Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 150

    1.

    Chlamydia screening: expanding the scope.

    Stamm WE.

    Ann Intern Med. 2004 Oct 5;141(7):570-2. No abstract available. PMID: 15466776 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Relative cost-effectiveness of different tests for Chlamydia trachomatis.

    Jackson B.

    Ann Intern Med. 2005 Feb 15;142(4):308; author reply 308-9. No abstract available. PMID: 15710968 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Screening asymptomatic women for Chlamydia trachomatis: abstract and commentary.

    Handsfield HH.

    JAMA. 1998 Nov 25;280(20):1800-1. No abstract available. PMID: 9842959 [PubMed - indexed for MEDLINE]Related articles

    4.

    A population based dynamic approach for estimating the cost effectiveness of screening for Chlamydia trachomatis.

    Welte R, Kretzschmar M, van den Hoek JA, Postma MJ.

    Sex Transm Infect. 2003 Oct;79(5):426. No abstract available. PMID: 14573849 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Screening for Chlamydia trachomatis; the Amsterdam experience.

    Bleker OP.

    Minerva Ginecol. 2000 Dec;52(12 Suppl 1):97-9. No abstract available. PMID: 11526697 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women]

    Ruitenberg EN.

    Ned Tijdschr Geneeskd. 1999 May 8;143(19):1012. Dutch. No abstract available. PMID: 10368724 [PubMed - indexed for MEDLINE]Related articles

    7.

    Summaries for patients. The cost-effectiveness of screening for Chlamydia in women 15 to 29 years of age.

    [No authors listed]

    Ann Intern Med. 2004 Oct 5;141(7):I29. No abstract available. PMID: 15466762 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Chlamydia trachomatis: common misperceptions and misunderstandings.

    Stevens-Simon C, Sheeder J.

    J Pediatr Adolesc Gynecol. 2005 Aug;18(4):231-43. Review. No abstract available. PMID: 16171726 [PubMed - indexed for MEDLINE]Related articles

    9.

    The silent epidemic of Chlamydia: what are we missing here?

    Sanfilippo JS.

    J Pediatr Adolesc Gynecol. 2008 Oct;21(5):231-2. No abstract available. PMID: 18794016 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infection in women.

    Gupta M, Hernon M, Gokhale R, Ghosh AK.

    Sex Transm Infect. 2002 Feb;78(1):76. No abstract available. PMID: 11872877 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Comparing cost effectiveness of screening women for Chlamydia trachomatis in systematic and opportunistic approaches.

    Postma MJ, Welte R, van den Hoek JA, Morré SA.

    Sex Transm Infect. 2002 Feb;78(1):73-4. No abstract available. PMID: 11872873 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Is screening for Chlamydia trachomatis infection cost effective?

    Paavonen J.

    Genitourin Med. 1997 Apr;73(2):103-4. Review. No abstract available. PMID: 9215090 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia.

    Walleser S, Salkeld G, Donovan B.

    Sex Health. 2006 Dec;3(4):225-34.PMID: 17112432 [PubMed - indexed for MEDLINE]Related articles

    14.

    Commentary: evidence synthesis and evidence consistency.

    Ades AE.

    Int J Epidemiol. 2004 Apr;33(2):426-7. No abstract available. PMID: 15082652 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Major improvements in cost effectiveness of screening women for Chlamydia trachomatis using pooled urine specimens and high performance testing.

    Morré SA, Welte R, Postma MJ.

    Sex Transm Infect. 2002 Feb;78(1):74-5. No abstract available. PMID: 11872874 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Towards screening for Chlamydia trachomatis]

    Kolmos HJ.

    Ugeskr Laeger. 1997 Aug 18;159(34):5104-5. Danish. No abstract available. PMID: 9297316 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cost-utility of repeated screening for Chlamydia trachomatis.

    de Vries R, van Bergen JE, de Jong-van den Berg LT, Postma MJ; PILOT-CT study group.

    Value Health. 2008 Mar-Apr;11(2):272-4.PMID: 18380639 [PubMed - indexed for MEDLINE]Related articles

    18.

    The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature.

    Gift TL, Blake DR, Gaydos CA, Marrazzo JM.

    Sex Transm Dis. 2008 Nov;35(11 Suppl):S51-60. Review.PMID: 18520977 [PubMed - indexed for MEDLINE]Related articles

    19.

    The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies.

    Hu D, Hook EW 3rd, Goldie SJ.

    Sex Transm Dis. 2006 Jul;33(7):428-36.PMID: 16572038 [PubMed - indexed for MEDLINE]Related articles

    20.

    Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data.

    de Vries R, van Bergen JE, de Jong-van den Berg LT, Postma MJ; PILOT-CT Study Group.

    Value Health. 2006 Jan-Feb;9(1):1-11.PMID: 16441519 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data